This week, the FDA officially removed Novo Nordisks popular weight-loss and diabetes medications, Wegovy and Ozempic , from its drug shortage list, indicating that supply now meets or exceeds U.S
Tirzepatide hits two
Semaglutide is a synthetic 31-amino-acid analogue of human GLP-1 (glucagon-like peptide-1), developed by Novo Nordisk and first authorized by Health Canada in 2018 under the brand name Ozempic
Mol Nutr Food Res (2017) 61(8)
To view a copy of this licence, visit About this article Cite this article Zheng, Z., Zong, Y., Ma, Y
Though Rogers reports no adverse effects from taking semaglutide, she also acknowledges that because these medications are so new, its still uncertain whether there could be long-term adverse effects waiting for her down the road: I dont know what will happen in 10 years will my ears fall off or will I grow a third eyebrow? But shes willing to take that chance in exchange for feeling better and running well now
